# US 2019/0054313 A1 · Surgically Positioned Neutron Flux Activated High Energy Therapeutic Charged Particle Generation System

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0054313 A1
- Document ID: US20190054313A1
- Status: Published application
- Kind: A1
- Application number: 16/102,063
- Filed: 2018-08-13
- Published: 2019-02-21
- Earliest claimed: 2017-08-15
- Assignees: Westinghouse Electric Corp.
- Applicants: Westinghouse Electric Company LLC
- Inventors: John H. Nelson; Michael D. Heibel
- Web page: https://patentgrep.com/patent/US20190054313A1

## CPC

- A61N 5/10: X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy (A61N5/01 takes precedence)
- A61K 41/009: {Neutron capture therapy, e.g. using uranium or non-boron material}
- A61N 5/1001: {using radiation sources introduced into or applied onto the body; brachytherapy}
- A61N 2005/109: {Neutrons}
- A61N 2005/1094: {Shielding, protecting against radiation}
- A61N 2005/1098: {Enhancing the effect of the particle by an injected agent or implanted device}
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

A process for treating highly localized carcinoma cells that provides precise positioning of a therapeutic source of highly ionizing but weakly penetrating radiation, which can be shaped so that it irradiates essentially only the volume of the tumor. The intensity and duration of the radiation produced by the source can be activated and deactivated by controlling the neutron flux generated by an array of electrically controlled neutron generators positioned outside the body being treated. The energy of the neutrons that interact with the source element can be adjusted to optimize the reaction rate of the ionized radiation production by utilizing neutron moderating material between the neutron generator array and the body. The source device may be left in place and reactivated as needed to ensure the tumor is eradicated without exposing the patient to any additional radiation between treatments. The source device may be removed once treatment is completed.

## Claims

### Claim 1

A method of treating localized carcinoma cells in a body of an animal comprising the steps of:
positioning a therapeutic source that is substantially nonradioactive when not exposed to a neutron source below a given activity, but becomes a source of highly ionizing but weakly penetrating radiation when exposed to a neutron field at or above the given activity, within the body in the vicinity of the carcinoma cells;
irradiating the therapeutic source from outside the body with a neutron field at or above the given activity for a prescribed period of time; and
repeating the irradiating step at prescribed intervals.

### Claim 2 (depends on 1)

The method of treating localized carcinoma cells of claim 1 wherein the therapeutic source of highly ionizing but weakly penetrating radiation comprises B4C, or P-31.

### Claim 3 (depends on 2)

The method of treating localized carcinoma cells of claim 2 wherein the B4C is enriched in B-10 content.

### Claim 4 (depends on 1)

The method of treating localized carcinoma cells of claim 1 wherein the therapeutic source of highly ionizing but weakly penetrating radiation is configured so it substantially only irradiates the carcinoma cells.

### Claim 5 (depends on 4)

The method of treating localized carcinoma cells of claim 4 wherein a radiation shield material that shields at least some of the highly ionizing radiation, but is substantially transparent to neutrons, is formed on a side of the therapeutic source not facing the carcinoma cells.

### Claim 6 (depends on 1)

The method of treating localized carcinoma cells of claim 1 wherein the positioning step includes the step of surgically implanting the therapeutic source approximately on the carcinoma cells.

### Claim 7 (depends on 1)

The method of treating localized carcinoma cells of claim 1 wherein the step of irradiating the therapeutic source includes the step of using an electric neutron generator to irradiate the therapeutic source.

### Claim 8 (depends on 7)

The method of treating localized carcinoma cells of claim 7 wherein the electric neutron generator is a Neutristor.

### Claim 9 (depends on 7)

The method of treating localized carcinoma cells of claim 7 wherein the electric neutron generator includes a plurality of electric neutron generators positioned around the body to irradiate the therapeutic source from different angles.

### Claim 10 (depends on 7)

The method of treating localized carcinoma cells of claim 7 including the step of using a neutron moderating material between the electric neutron generator and the therapeutic source to adjust the neutron energy to optimize the highly ionizing, but weakly penetrating radiation produced by the therapeutic source.

### Claim 11 (depends on 10)

The method of treating localized carcinoma cells of claim 10 wherein the neutron moderating material comprises D2O or C.

### Claim 12 (depends on 10)

The method of treating localized carcinoma cells of claim 10 wherein the step of using the neutron moderating material includes the step of placing the neutron moderating material outside the body.

### Claim 13 (depends on 1)

The method of treating localized carcinoma cells of claim 1 including the step of leaving the therapeutic source within the body between treatments of treating the localized carcinoma cells.

### Claim 14 (depends on 13)

The method of treating localized carcinoma cells of claim 13 including the step of removing the therapeutic source from the body once treatment of the localized carcinoma cells is completed.

### Claim 15 (depends on 1)

The method of treating localized carcinoma cells of claim 1 wherein the therapeutic source comprises one or more very thin disks or plates in the order of a micron's thickness with a sufficient combined surface area to ensure the entire volume of localized carcinoma cells will be affected by the highly ionizing but weakly penetrating radiation when one or more of the disks or plates are emplaced around the carcinoma cells and irradiated with the neutron field.

### Claim 16 (depends on 1)

The method of treating localized carcinoma cells of claim 1 wherein the therapeutic source is configured from a material that produces high energy alpha or beta particles and either no or low energy gamma radiation.

### Claim 17 (depends on 16)

The method of treating localized carcinoma cells of claim 16 wherein the therapeutic source material is insoluble in water, non-toxic to the body and has short half-lives.

### Claim 18 (depends on 1)

The method of treating localized carcinoma cells of claim 1 including the step of using a gamma spectrometer to monitor the intensity of gamma radiation emitted by a product of the neutron radiation of the therapeutic source material while a charged particle production rate can be monitored while the neutron irradiation is occurring.

### Claim 19 (depends on 18)

The method of treating localized carcinoma cells of claim 18 using the monitored intensity of the gamma radiation and neutron activity of the neutron field to determine a radiation dose that has been applied to the body.

### Claim 20 (depends on 19)

The method of treating localized carcinoma cells of claim 19 controlling the intensity of the neutron field based on the monitored gamma intensity and the radiation dose.
